{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T10:04:10Z","timestamp":1788084250734,"version":"build-2784847793"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2377-9-63","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T19:15:13Z","timestamp":1261509313000},"source":"Crossref","is-referenced-by-count":127,"title":["Amyloid and tau cerebrospinal fluid biomarkers in HIV infection"],"prefix":"10.1186","volume":"9","author":[{"given":"Magnus","family":"Gissl\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Krut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Andreasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cinque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J","family":"Brew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Spudich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,22]]},"reference":[{"issue":"4","key":"277_CR1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1086\/514001","volume":"175","author":"BJ Brew","year":"1997","unstructured":"Brew BJ, Pemberton L, Cunningham P, Law MG: Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis. 1997, 175 (4): 963-966. 10.1086\/514001.","journal-title":"J Infect Dis"},{"issue":"5","key":"277_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.410420503","volume":"42","author":"RJ Ellis","year":"1997","unstructured":"Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA: Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol. 1997, 42 (5): 679-688. 10.1002\/ana.410420503.","journal-title":"Ann Neurol"},{"issue":"4","key":"277_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00126334-199908010-00003","volume":"21","author":"M Gisslen","year":"1999","unstructured":"Gisslen M, Fuchs D, Svennerholm B, Hagberg L: Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr. 1999, 21 (4): 271-276.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"277_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2334-5-98","volume":"5","author":"SS Spudich","year":"2005","unstructured":"Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, Deeks SG, Paxinos EE, Price RW: Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis. 2005, 5: 98-10.1186\/1471-2334-5-98.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"277_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/infdis\/158.5.1079","volume":"158","author":"RW Price","year":"1988","unstructured":"Price RW, Brew BJ: The AIDS dementia complex. J Infect Dis. 1988, 158 (5): 1079-1083.","journal-title":"J Infect Dis"},{"issue":"4","key":"277_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.410380404","volume":"38","author":"BJ Brew","year":"1995","unstructured":"Brew BJ, Rosenblum M, Cronin K, Price RW: AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol. 1995, 38 (4): 563-570. 10.1002\/ana.410380404.","journal-title":"Ann Neurol"},{"issue":"3","key":"277_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ana.10827","volume":"55","author":"A d'Arminio Monforte","year":"2004","unstructured":"d'Arminio Monforte A, Cinque P, Mocroft A, Goebel FD, Antunes F, Katlama C, Justesen US, Vella S, Kirk O, Lundgren J: Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol. 2004, 55 (3): 320-328. 10.1002\/ana.10827.","journal-title":"Ann Neurol"},{"issue":"4","key":"277_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/003655400750044926","volume":"32","author":"M Gisslen","year":"2000","unstructured":"Gisslen M, Svennerholm B, Norkrans G, Franzen C, Sall C, Svensson R, Oberg S, Hagberg L: Cerebrospinal fluid and plasma viral load in HIV-1-infected patients with various anti-retroviral treatment regimens. Scand J Infect Dis. 2000, 32 (4): 365-369. 10.1080\/003655400750044926.","journal-title":"Scand J Infect Dis"},{"issue":"6","key":"277_CR9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/135965350501000607","volume":"10","author":"A Mellgren","year":"2005","unstructured":"Mellgren A, Antinori A, Cinque P, Price RW, Eggers C, Hagberg L, Gisslen M: Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment. Antivir Ther. 2005, 10 (6): 701-707.","journal-title":"Antivir Ther"},{"issue":"12","key":"277_CR10","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1086\/508750","volume":"194","author":"S Spudich","year":"2006","unstructured":"Spudich S, Lollo N, Liegler T, Deeks SG, Price RW: Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure. J Infect Dis. 2006, 194 (12): 1686-1696. 10.1086\/508750.","journal-title":"J Infect Dis"},{"issue":"Suppl 3","key":"277_CR11","doi-asserted-by":"publisher","first-page":"S294","DOI":"10.1086\/533419","volume":"197","author":"RW Price","year":"2008","unstructured":"Price RW, Spudich S: Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis. 2008, 197 (Suppl 3): S294-306. 10.1086\/533419.","journal-title":"J Infect Dis"},{"issue":"5","key":"277_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/QAI.0b013e318162754f","volume":"47","author":"E Sinclair","year":"2008","unstructured":"Sinclair E, Ronquillo R, Lollo N, Deeks SG, Hunt P, Yiannoutsos CT, Spudich S, Price RW: Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection. J Acquir Immune Defic Syndr. 2008, 47 (5): 544-552. 10.1097\/QAI.0b013e318162754f.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"277_CR13","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1097\/00002030-200401001-00012","volume":"18","author":"VG Valcour","year":"2004","unstructured":"Valcour VG, Shikuma CM, Watters MR, Sacktor NC: Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS. 2004, 18 (Suppl 1): S79-86.","journal-title":"AIDS"},{"issue":"5","key":"277_CR14","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.mehy.2007.02.030","volume":"69","author":"JM Alisky","year":"2007","unstructured":"Alisky JM: The coming problem of HIV-associated Alzheimer's disease. Med Hypotheses. 2007, 69 (5): 1140-1143. 10.1016\/j.mehy.2007.02.030.","journal-title":"Med Hypotheses"},{"issue":"2","key":"277_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11481-009-9151-9","volume":"4","author":"L Pulliam","year":"2009","unstructured":"Pulliam L: HIV regulation of amyloid beta production. J Neuroimmune Pharmacol. 2009, 4 (2): 213-217. 10.1007\/s11481-009-9151-9.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"6","key":"277_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00401-006-0037-0","volume":"111","author":"IC Anthony","year":"2006","unstructured":"Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE: Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol. 2006, 111 (6): 529-538. 10.1007\/s00401-006-0037-0.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"277_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/13550280490279816","volume":"10","author":"BB Gelman","year":"2004","unstructured":"Gelman BB, Schuenke K: Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. J Neurovirol. 2004, 10 (2): 98-108. 10.1080\/13550280490279816.","journal-title":"J Neurovirol"},{"issue":"1","key":"277_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jnnp.65.1.29","volume":"65","author":"MM Esiri","year":"1998","unstructured":"Esiri MM, Biddolph SC, Morris CS: Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry. 1998, 65 (1): 29-33. 10.1136\/jnnp.65.1.29.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"277_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","volume":"19","author":"DA Green","year":"2005","unstructured":"Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL: Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. Aids. 2005, 19 (4): 407-411. 10.1097\/01.aids.0000161770.06158.5c.","journal-title":"Aids"},{"issue":"5","key":"277_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000100926","volume":"23","author":"O Hansson","year":"2007","unstructured":"Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, Blennow K: Prediction of Alzheimer's disease using the CSF Abeta42\/Abeta40 ratio in patients with mild cognitive impairment. Dement Geriatr Cogn Disord. 2007, 23 (5): 316-320. 10.1159\/000100926.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"277_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, et al: Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol. 2009, 65 (4): 403-413. 10.1002\/ana.21610.","journal-title":"Ann Neurol"},{"issue":"9","key":"277_CR22","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1212\/01.wnl.0000183293.95787.b7","volume":"65","author":"BJ Brew","year":"2005","unstructured":"Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L: CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology. 2005, 65 (9): 1490-1492. 10.1212\/01.wnl.0000183293.95787.b7.","journal-title":"Neurology"},{"issue":"2","key":"277_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S0022-510X(99)00253-1","volume":"171","author":"L Andersson","year":"1999","unstructured":"Andersson L, Blennow K, Fuchs D, Svennerholm B, Gisslen M: Increased cerebrospinal fluid protein tau concentration in neuro-AIDS. J Neurol Sci. 1999, 171 (2): 92-96. 10.1016\/S0022-510X(99)00253-1.","journal-title":"J Neurol Sci"},{"issue":"1","key":"277_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3940(98)00549-7","volume":"254","author":"RJ Ellis","year":"1998","unstructured":"Ellis RJ, Seubert P, Motter R, Galasko D, Deutsch R, Heaton RK, Heyes MP, McCutchan JA, Atkinson JH, Grant I: Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans. HIV Neurobehavioral Research Center Group (HNRC). Neurosci Lett. 1998, 254 (1): 1-4. 10.1016\/S0304-3940(98)00549-7.","journal-title":"Neurosci Lett"},{"issue":"6","key":"277_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/sti.76.6.443","volume":"76","author":"AJ Green","year":"2000","unstructured":"Green AJ, Giovannoni G, Hall-Craggs MA, Thompson EJ, Miller RF: Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease. Sex Transm Infect. 2000, 76 (6): 443-446. 10.1136\/sti.76.6.443.","journal-title":"Sex Transm Infect"},{"key":"277_CR26","unstructured":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992, 41 (RR-17): 1-19."},{"key":"277_CR27","doi-asserted-by":"crossref","unstructured":"Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991, 41 (6): 778-785.","DOI":"10.1212\/WNL.41.6.778"},{"issue":"18","key":"277_CR28","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, et al: Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007, 69 (18): 1789-99. 10.1212\/01.WNL.0000287431.88658.8b.","journal-title":"Neurology"},{"issue":"1","key":"277_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/13550289809113490","volume":"4","author":"P Cinque","year":"1998","unstructured":"Cinque P, Cleator GM, Weber T, Monteyne P, Sindic C, Gerna G, van Loon AM, Klapper PE: Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis. J Neurovirol. 1998, 4 (1): 120-132. 10.3109\/13550289809113490.","journal-title":"J Neurovirol"},{"issue":"1-2","key":"277_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0166-0934(97)00152-3","volume":"69","author":"T Weber","year":"1997","unstructured":"Weber T, Klapper PE, Cleator GM, Bodemer M, Luke W, Knowles W, Cinque P, Van Loon AM, Grandien M, Hammarin AL, et al: Polymerase chain reaction for detection of JC virus DNA in cerebrospinal fluid: a quality control study. European Union Concerted Action on Viral Meningitis and Encephalitis. J Virol Methods. 1997, 69 (1-2): 231-237. 10.1016\/S0166-0934(97)00152-3.","journal-title":"J Virol Methods"},{"issue":"7","key":"277_CR31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984, 34 (7): 939-944.","journal-title":"Neurology"},{"key":"277_CR32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/978-1-4615-5337-3_110","volume-title":"Progress in Alzheimer's and Parkinson's Diseases","author":"H Vanderstichele","year":"1998","unstructured":"Vanderstichele H, Blennow K, D'Heuvaert N, Buyse M, Wallin A, Andreasen N, Seubert P, Voorde Van De A, Vanmechelen E: Development of a specific diagnostic test for measurement of amyloid(1-42) beta in CSF. Progress in Alzheimer's and Parkinson's Diseases. Edited by: Fisher A, Hanin I, Yoshida M. 1998, New York: Plenum Press, 773-778."},{"issue":"3","key":"277_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E: Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol Chem Neuropathol. 1995, 26 (3): 231-245. 10.1007\/BF02815140.","journal-title":"Mol Chem Neuropathol"},{"issue":"1","key":"277_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","volume":"285","author":"E Vanmechelen","year":"2000","unstructured":"Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Perre Van Der B, Sjogren M, Andreasen N, Blennow K: Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett. 2000, 285 (1): 49-52. 10.1016\/S0304-3940(00)01036-3.","journal-title":"Neurosci Lett"},{"key":"277_CR35","volume-title":"Multi- and Megavariate Data Analysis Part I: Basic Principles and Applications. Second revised and enlarged edition","author":"L Eriksson","year":"2006","unstructured":"Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikstr\u00f6m C, Wold S: Multi- and Megavariate Data Analysis Part I: Basic Principles and Applications. Second revised and enlarged edition. 2006, Umea, Sweden: UMETRICS"},{"issue":"4","key":"277_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jama.2009.1064","volume":"302","author":"N Mattsson","year":"2009","unstructured":"Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, Flier van der WM, Blankenstein MA, Ewers M, et al: CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009, 302 (4): 385-393. 10.1001\/jama.2009.1064.","journal-title":"JAMA"},{"issue":"18","key":"277_CR37","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1212\/01.wnl.0000278457.55877.eb","volume":"69","author":"RW Price","year":"2007","unstructured":"Price RW, Epstein LG, Becker JT, Cinque P, Gisslen M, Pulliam L, McArthur JC: Biomarkers of HIV-1 CNS infection and injury. Neurology. 2007, 69 (18): 1781-1788. 10.1212\/01.wnl.0000278457.55877.eb.","journal-title":"Neurology"},{"issue":"9533","key":"277_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H: Alzheimer's disease. Lancet. 2006, 368 (9533): 387-403. 10.1016\/S0140-6736(06)69113-7.","journal-title":"Lancet"},{"issue":"2","key":"277_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1602\/neurorx.1.2.213","volume":"1","author":"K Blennow","year":"2004","unstructured":"Blennow K: Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx. 2004, 1 (2): 213-225. 10.1602\/neurorx.1.2.213.","journal-title":"NeuroRx"},{"issue":"1","key":"277_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11481-006-9035-1","volume":"2","author":"M Gisslen","year":"2007","unstructured":"Gisslen M, Hagberg L, Rosengren L, Brew BJ, Cinque P, Spudich S, Price RW: Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers. J Neuroimmune Pharmacol. 2007, 2 (1): 112-119. 10.1007\/s11481-006-9035-1.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"277_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2217\/17520363.1.1.59","volume":"1","author":"U Andreasson","year":"2007","unstructured":"Andreasson U, Portelius E, Andersson M, Blennow K, Zetterberg H: Aspects of beta-amyloid as a biomarker for Alzheimer's disease. Biomarkers Med. 2007, 1 (1): 59-78. 10.2217\/17520363.1.1.59.","journal-title":"Biomarkers Med"},{"issue":"1","key":"277_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0014-4886(03)00027-X","volume":"183","author":"A Olsson","year":"2003","unstructured":"Olsson A, Hoglund K, Sjogren M, Andreasen N, Minthon L, Lannfelt L, Buerger K, Moller HJ, Hampel H, Davidsson P, et al: Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Exp Neurol. 2003, 183 (1): 74-80. 10.1016\/S0014-4886(03)00027-X.","journal-title":"Exp Neurol"},{"issue":"8","key":"277_CR43","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","volume":"65","author":"H Zetterberg","year":"2008","unstructured":"Zetterberg H, Andreasson U, Hansson O, Wu G, Sankaranarayanan S, Andersson ME, Buchhave P, Londos E, Umek RM, Minthon L, et al: Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch Neurol. 2008, 65 (8): 1102-1107. 10.1001\/archneur.65.8.1102.","journal-title":"Arch Neurol"},{"key":"277_CR44","volume-title":"Mol Psychiatry","author":"P Lewczuk","year":"2008","unstructured":"Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J, Burger K, Hampel H, Frolich L, Wolf S, et al: Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry. 2008"},{"issue":"4","key":"277_CR45","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","volume":"60","author":"D Strozyk","year":"2003","unstructured":"Strozyk D, Blennow K, White LR, Launer LJ: CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology. 2003, 60 (4): 652-656.","journal-title":"Neurology"},{"issue":"3","key":"277_CR46","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.20730","volume":"59","author":"AM Fagan","year":"2006","unstructured":"Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, et al: Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol. 2006, 59 (3): 512-519. 10.1002\/ana.20730.","journal-title":"Ann Neurol"},{"issue":"5","key":"277_CR47","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/00002030-200103300-00005","volume":"15","author":"M Nebuloni","year":"2001","unstructured":"Nebuloni M, Pellegrinelli A, Ferri A, Bonetto S, Boldorini R, Vago L, Grassi MP, Costanzi G: Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients. Aids. 2001, 15 (5): 571-575. 10.1097\/00002030-200103300-00005.","journal-title":"Aids"},{"issue":"4","key":"277_CR48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991, 41 (4): 479-486.","journal-title":"Neurology"},{"issue":"2","key":"277_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00002030-200501280-00004","volume":"19","author":"HC Rempel","year":"2005","unstructured":"Rempel HC, Pulliam L: HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS. 2005, 19 (2): 127-135. 10.1097\/00002030-200501280-00004.","journal-title":"AIDS"},{"issue":"2","key":"277_CR50","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","volume":"4","author":"CL Achim","year":"2009","unstructured":"Achim CL, Adame A, Dumaop W, Everall IP, Masliah E: Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol. 2009, 4 (2): 190-199. 10.1007\/s11481-009-9152-8.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"277_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/jnen\/61.1.85","volume":"61","author":"JL Mankowski","year":"2002","unstructured":"Mankowski JL, Queen SE, Tarwater PM, Fox KJ, Perry VH: Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol. 2002, 61 (1): 85-90.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1-2","key":"277_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0304-3940(01)02285-6","volume":"314","author":"M Sjogren","year":"2001","unstructured":"Sjogren M, Gisslen M, Vanmechelen E, Blennow K: Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Neurosci Lett. 2001, 314 (1-2): 33-36. 10.1016\/S0304-3940(01)02285-6.","journal-title":"Neurosci Lett"},{"issue":"4","key":"277_CR53","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/1352458508100031","volume":"15","author":"N Mattsson","year":"2009","unstructured":"Mattsson N, Axelsson M, Haghighi S, Malmestrom C, Wu G, Anckarsater R, Sankaranarayanan S, Andreasson U, Fredrikson S, Gundersen A, et al: Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis. Mult Scler. 2009, 15 (4): 448-454. 10.1177\/1352458508100031.","journal-title":"Mult Scler"},{"issue":"6","key":"277_CR54","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ana.410190603","volume":"19","author":"BA Navia","year":"1986","unstructured":"Navia BA, Cho ES, Petito CK, Price RW: The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986, 19 (6): 525-535. 10.1002\/ana.410190603.","journal-title":"Ann Neurol"},{"issue":"2","key":"277_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/37.2.2492045","volume":"37","author":"JQ Trojanowski","year":"1989","unstructured":"Trojanowski JQ, Schuck T, Schmidt ML, Lee VM: Distribution of tau proteins in the normal human central and peripheral nervous system. J Histochem Cytochem. 1989, 37 (2): 209-215.","journal-title":"J Histochem Cytochem"},{"issue":"4 Suppl","key":"277_CR56","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/S0197-4580(97)00062-6","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E: Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging. 1997, 18 (4 Suppl): S85-88. 10.1016\/S0197-4580(97)00062-6.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"277_CR57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00005072-199405000-00003","volume":"53","author":"LC Stanley","year":"1994","unstructured":"Stanley LC, Mrak RE, Woody RC, Perrot LJ, Zhang S, Marshak DR, Nelson SJ, Griffin WS: Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol. 1994, 53 (3): 231-238. 10.1097\/00005072-199405000-00003.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"277_CR58","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/jnen\/64.6.529","volume":"64","author":"IC Anthony","year":"2005","unstructured":"Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE: Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol. 2005, 64 (6): 529-536.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"277_CR59","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.410190602","volume":"19","author":"BA Navia","year":"1986","unstructured":"Navia BA, Jordan BD, Price RW: The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986, 19 (6): 517-524. 10.1002\/ana.410190602.","journal-title":"Ann Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-9-63.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-9-63\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-9-63","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:30:30Z","timestamp":1685320230000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-9-63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["277"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-9-63","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]},"article-number":"63"}}